Delivery strategies to enhance mucosal vaccination

Bibliography

• Heystek HC, Moulon C, Woltman AM, et al. Human immature dendritic cells efficiently bind and take up Secretory IgA without the induction of maturation. J Immunol 2002;168:102-7
   PubMed Web of Science ®Google Scholar
• Ogra PL, Faden H, Welliver RC. Vaccination strategies for mucosal immune responses. Clin Microbiol Rev 2001;14:430-45
   PubMed Web of Science ®Google Scholar
• Clark MA, Jepson MA, Hirst BH. Exploiting M cells for drug and vaccine delivery. Adv Drug Deliv Rev 2001;50:81-106
   PubMed Web of Science ®Google Scholar
• Brandtzaeg P, Kiyono H, Pabst R, Russell MW. Terminology: nomenclature of mucosa-associated lymphoid tissue. Mucosal Immunol 2008;1:31-7
   PubMed Web of Science ®Google Scholar
• Neutra MR. Interactions of viruses and microparticles with apical plasma membranes of M cells: implications for human immunodeficiency virus transmission. J Infectious Dis 1999;179:S441-3
   Google Scholar
• Neutra MR. Current concepts in mucosal immunity V. Role of M cells in transepithelial transport of antigens and pathogens to the mucosal immune system. Am J Gastrointest Liver Physiol 1998;274:785-91
   PubMed Web of Science ®Google Scholar
• Jang MH, Kweon MN, Iwatani K, et al. Intestinal villous M cells: an antigen entry site in the mucosal epithelium. PNAS 2004;101:6110-5
   PubMed Web of Science ®Google Scholar
• Gebert A, Steinmetz I, Fassbender S, Wendlandt KH. Antigen transport into Peyer's patches: increased uptake by constant numbers of M cells. Am J Pathol 2004;164:65-72
   PubMed Web of Science ®Google Scholar
• Van Der Lubben IM, Verhoef JC, Borchard G, Junginger HE. Chitosan for mucosal vaccination. Adv Drug Deliv Rev 2001;52:139-44
   PubMed Web of Science ®Google Scholar
• Fujihashi K, Dohi T, Rennert PD, et al. Peyer's patches are requried for oral tolerance to proteins. PNAS 2001;98:3310-5
   PubMed Web of Science ®Google Scholar
• Van Ginkel FW, Nguyen HH, McGhee JR. Vaccines for mucosal immunity to combat emerging infectious diseases. Emerg Infectious Dis 2000;6:123-32
   PubMed Web of Science ®Google Scholar
• Goodsell A, Zhou F, Gupta S, et al. β7-integrin-independent enhancement of mucosal and systemic anti-HIV antibody responses following combined mucosal and systemic gene delivery. Immunology 2007;123:378-89
   PubMed Web of Science ®Google Scholar
• Kieny MP, Excler JL, Girard M. Research and development of new vaccines against infectious diseases. Am J Public Health 2004;94:1931-5
   PubMed Web of Science ®Google Scholar
• Webster D, Gahan ME, Strugnell RA, Wesselingh SL. Advances in oral vaccine delivery options: What is on the horizon? Am J Drug Deliv 2003;1:227-40
   Google Scholar
• Burgdorf S, Kautz A, Bohnert V, et al. Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation. Science 2007;316:612-6
   PubMed Web of Science ®Google Scholar
• Malyguine A, Strobl SL, Shafer-Weaver KA, et al. A modified human ELISPOT assay to detect specific responses to primary tumor cell targets. J Transl Med 2004;2(1):9 Published online 29 March 2004, doi:10.1186/1479-5876-2-9
   PubMedGoogle Scholar
• Rosemberg SA. Progress in human tumour immunology and immunotherapy. Nature 2001;411:380-4
   PubMed Web of Science ®Google Scholar
• Bermu´dez-Humara´n LG, Cortes-Perez NG, Lefe`vre F, et al. A novel mucosal vaccine based on live lactococci expressing E7 antigen and IL-12 induces systemic and mucosal immune responses and protects mice against human papillomavirus type 16-induced tumors. J Immunol 2005;175:7297-302
   PubMed Web of Science ®Google Scholar
• Lowy DR, Schiller JT. Prophylactic human papillomavirus vaccines. J Clin Invest 2006;116:1167-73
   PubMed Web of Science ®Google Scholar
• Ahuja SS, Estrada CA, Lindsey ML. Crosstalk between cytotoxic T-lymphocyte associated antigen-4 and interleukin-12 in cytotoxic T-lymphocyte mediated myocarditis: adding another link to the chain. Circ Res 2007;101:218-20
   Google Scholar
• Brandtzaeg P. Nature and function of gastrointestinal antigen-presenting cells. Allergy 2001;56:16-20
   PubMed Web of Science ®Google Scholar
• Srivastava IK, Singh M. DNA vaccines: focus on increasing potency and efficacy. Int J Pharm Med 2005;19:15-28
   Google Scholar
• Cossart P, Sansonetti PJ. Bacterial invasion: the paradigms of enteroinvasive pathogens. Science 2004;304:242-8
   PubMed Web of Science ®Google Scholar
• Roche S, Rey FA, Gaudin Y, Bressanelli S. Structure of the prefusion form of the vesicular stomatitis virus glycoprotein G. Science 2007;315:843-8
   PubMed Web of Science ®Google Scholar
• Sansonetti PJ, Di Santo JP. Debugging how bacteria manipulate the immune response. Immunity 2007;26:149-61
   PubMed Web of Science ®Google Scholar
• Horwitz MA, Harth G, Dillon, BJ, Masleša-Galic S. Recombinant bacillus Calmette-Guérin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model. Proc Natl Acad Sci USA 2000;97(25):13853-8
   PubMed Web of Science ®Google Scholar
• Khader SA, Bell GK, Pearl JE, et al. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol 2007;8:369-77
   PubMed Web of Science ®Google Scholar
• Bhavsar MD, Amiji MM. Development of novel biodegradable polymeric nanoparticles-in-microsphere formulation for local plasmid DNA delivery in the gastrointestinal tract. AAPS PharmSciTech 2008;9:288-94
   PubMed Web of Science ®Google Scholar
• Azad N, Rojanasakul Y. Nanobiotechnology in drug delivery. Am J Drug Deliv 2006;4:79-88
   Google Scholar
• Wells JM, Mercenier A. Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria. Nat Rev Microbiol 2008;6:349-62
   PubMed Web of Science ®Google Scholar
• Donnelly JJ, Wahren B, Liu MA, et al. DNA vacines: progress and challenges. J Immunol 2005;175:633-9
   PubMed Web of Science ®Google Scholar
• Kahatri K, Goyal AK, Gupta PN, et al. Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B. Int J Pharm 2008;354:235-41
   PubMedGoogle Scholar
• Bhavsar MD, Amiji MM. Polymeric nano- and microparticle technologies for oral gene delivery. Expert Opin Drug Deliv 2007;4:197-213
   PubMed Web of Science ®Google Scholar
• Wang J, Thorson L, Stokes RW, et al. Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis. J Immunol 2004;173:6357-65
   PubMed Web of Science ®Google Scholar
• Lin SW, Hensley SE, Tatsis N, et al. Recombinant adeno-associated virus vectors induce functionally impaired transgene product-specific CD8+ T cells in mice. J Clin Invest 2007;117:3958-70
   PubMed Web of Science ®Google Scholar
• Boyer JD, Cohen AD, Vogt S, et al. Vaccination of seronegative volunteers with a human immunodeficiency virus Type 1 env/rev DNA vaccine induces antigen-specific proliferation and lymphocyte production of β-chemokines. J Infect Dis 2000;181:476-83
   PubMed Web of Science ®Google Scholar
• Maecker HT, Hansen G, Walter DM, et al. Vaccination with allergen-IL-18 fusion DNA protects against, and reverses established, airway hyperreactivity in a murine asthma model. J Immunol 2001;166:959-65
   PubMed Web of Science ®Google Scholar
• Maecker H, Umetsu DT, DeKruyff RH, Levy S. DNA vaccination with cytokine fusion constructs biases the immune response to ovalbumin. Vaccine 1997;15:1687-96
   PubMed Web of Science ®Google Scholar
• Belyakov IM, Isakov D, Zhu Q, et al. A novel functional CTL avidity/activity compartmentalization to the site of mucosal immunization contributes to protection of macaques against simian/human immunodeficiency viral depletion of mucosal CD4+ T cells. J Immunol 2007;178:7211-21
   PubMed Web of Science ®Google Scholar
• Badovinac VP, Messingham KA, Jabbari A, et al. Accelerated CD8+ T-cell memory and prime-boost response after dendritic-cell vaccination. Nat Med 2005;11:748-56
   PubMed Web of Science ®Google Scholar
• Yanagita M, Hiroi T, Kitagaki N, et al. Nasopharyngeal-associated lymphoreticular tissue (NALT) immunity: fimbriae-specific Th1 and Th2 cell-regulated IgA responses for the inhibition of bacterial attachment to epithelial cells and subsequent inflammatory cytokine production. J Immunol 1999;162:3559-65
   PubMed Web of Science ®Google Scholar
• Gallichan WS, Rosenthal KL. Long-lived cytotoxic T lymphocyte memory in mucosal tissue after mucosal but not systemic immunization. J Exp Med 1996;184:1879-90
   PubMed Web of Science ®Google Scholar
• Tanghe A, D'Souza S, Rosseels V. Improved immunogenicty and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting. Infect Immun 2001;69:3041-7
   PubMed Web of Science ®Google Scholar
• Horner AA, Datta SK, Takabayashi K, et al. Immunostimulatory DNA-based vaccines elicit multifaceted immune responses against HIV at systemic and mucosal sites. J Immunol 2001;167:1584-91
   PubMed Web of Science ®Google Scholar
• Gelperina S, Kisich K, Iseman MD, Heifets L. The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis. Am J Respir Crit Care Med 2005;172:1487-90
   PubMed Web of Science ®Google Scholar
• Ishii T, Okahata Y, Sato T. Mechanism of cell transfection with plasmid/chitosan complexes. Biochemica et Biophysica Acta 2001;1514:51-64
   PubMed Web of Science ®Google Scholar
• Bhavsar MD, Amiji MM. Gastrointestinal distribution and in vivo gene transfection studies with nanoparticles-in-microsphere oral system (NiMOS). J Control Release 2007;119:339-48
   PubMed Web of Science ®Google Scholar
• Champion JA, Mitragotri S. Role of target geometry in phagocytosis. PNAS 2006;103:4930-4
   PubMed Web of Science ®Google Scholar
• Borchard G. Chitosans for gene delivery. Adv Drug Deliv Rev 2001;52:145-50
   PubMed Web of Science ®Google Scholar
• Ganta S, Devalapally H, Shahiwala A, Amiji M. A review of stimuli-responsive nanocarriers for drug and gene delivery. J Control Release 2008;126:187-204
   PubMed Web of Science ®Google Scholar
• Devalapally H, Duan Z, Seiden MV, Amiji MM. Modulation of drug resistance in ovarian adenocarcinoma by enhancing intracellular ceramide using tamoxifen-loaded biodegradable polymeric nanoparticles. Clin Cancer 2008;14:3193-203
   PubMed Web of Science ®Google Scholar
• van Vlerken LE, Duan Z, Little SR, et al. Biodistribution and pharmacokinetic analysis of paclitaxel and ceramide administered in multifunctional polymer-blend nanoparticles in drug resistant breast cancer model. Mol Pharm 2008;5:516-26
   PubMed Web of Science ®Google Scholar
• Bhavsar MD, Tiwari SB, Amiji MM. Formulation optimization for the nanoparticles-in-microsphere hybrid oral delivery system using factorial design. J Control Release 2006;110:422-30
   PubMed Web of Science ®Google Scholar
• Talsma SS, Babensee JE, Murthy N, Williams IR. Development and in vitro validation of a targeted delivery vehicle for DNA vaccines. J Control Release 2006;112:271-9
   PubMed Web of Science ®Google Scholar
• Diebold SS, Cotten M, Koch N, Zenke M. MHC class II presentation of endogenously expressed antigens by transfected dendritic cells. Gene Ther 2001;8:487-93
   PubMed Web of Science ®Google Scholar
• Jain RA. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials 2000;21:2475-90
   PubMed Web of Science ®Google Scholar
• Lamprecht A, Ubrich N, Yamamoto H, et al. Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease. J Pharmacol Exp Ther 2001;299:775-81
   PubMed Web of Science ®Google Scholar
• Fremont DH, Stura EA, Matsumura M, et al. Crystal structure of an H-2Kb-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding groove. Immunology 1995;92:2479-83
   Google Scholar
• Kim TS, DeKruyff RH, Rupper R. An ovalbumin-IL-12 fusion protein is more effective than ovalbumin plus free recombinant IL-12 in inducing a T helper cell type 1-dominated immune response and inhibiting antigen-specific IgE production. J Immunol 1997;158:4137-44
   PubMed Web of Science ®Google Scholar
• Kaul G, Amiji M. Tumor-targeted gene delivery using poly(ethylene glycol)-modified gelatin nanoparticles: in vitro and in vivo studies. Pharm Res 2005;22:951-61
   PubMed Web of Science ®Google Scholar
• Zwiorek K, Kloeckner J, Wagner E, Coester C. Gelatin nanoparticles as a new and simple gene delivery system. J Pharm Pharm Sci 2004;7:22-8
   Google Scholar
• Baca-Estrada ME, Foldvari M, Babuik SL, Babuik LA. Vaccine delivery: lipid-based delivery systems. J Biotechnol 2000;83:91-104
   PubMed Web of Science ®Google Scholar
• Filipović-Grčić J, Škalko-Basnet N, JalŠienjak I. Mucoadhesive chitosan-coated liposomes: characteristics and stability. J Microencapsul 2001;18:3-12
   PubMed Web of Science ®Google Scholar
• Torchilin VP, Rammohan R, Weissig V, Levchenko TS. TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors. PNAS 2001;98:8786-91
   PubMed Web of Science ®Google Scholar
• Sakaue G, Hiroi T, Nakagawa Y, et al. HIV mucosal vaccine: nasal immunization with gp160-encapsulated hemagglutinating virus of Japan-liposome induces antigen-specific CTLs and neutralizing antibody responses. J Immunol 2003;170:495-502
   PubMed Web of Science ®Google Scholar
• Kwak LW, Pennington R, Boni L, et al. Cutting edge: Liposomal formulation of a self lymphoma antigen induces potent protective antitumor immunity. J Immunol 1998;160:3637-41
   PubMed Web of Science ®Google Scholar
• Allison AC. Squalene and squalane emulsions as adjuvants. Methods 1999;19:87-93
   PubMed Web of Science ®Google Scholar
• Bozkir A, Hayta G. Preparation and evaluation of multiple emulsions water-in-oil-in-water (w/o/w) as delivery system for influenza virus antigens. J Drug Target 2004;12:157-64
   PubMed Web of Science ®Google Scholar
• Hanson JA, Chang CB, Graves SM, et al. Nanoscale double emulsions stabilized by single-component block copolypeptides. Nature 2008;455:85-8
   PubMed Web of Science ®Google Scholar
• Shahiwala A, Amiji MM. Enhanced mucosal and systemic immune response with sqalane oil-containing multiple emulsions upon intranasal and oral administration in mice. J Drug Target 2008;16:302-10
   PubMed Web of Science ®Google Scholar
• Yih TC, Al-Fandi M. Engineered nanoparticles as precise drug delivery systems. J Cell Biochem 2006;97:1184-90
   PubMed Web of Science ®Google Scholar
• Bhattacharya R, Mukherjee P. Biological properties of “naked” metal nanoparticles. Adv Drug Deliv Rev 2008;60:1289-306
   PubMed Web of Science ®Google Scholar
• Mukherjee P, Bhattacharya R, Bone N, et al. Potential therapeutic application of gold nanoparticles in B-chronic lymphocytic leukemia (BCLL): enhancing apoptosis. J Nanobiotechnol 2007;5:4. Published online 8 May 2007doi:10.1186/1477-3155-5-4
   PubMedGoogle Scholar
• Greenberg RS, Maxwell LG, Zahurak M, Yaster M. Preanesthetic medication of children with midazolam using the biojector jet injector. Anesthesiology 1995;83:264-9
   PubMed Web of Science ®Google Scholar
• Harrison RA, Bianco AE. DNA immunization with Onchocerca volvulus genes, Ov-tmy-1 and OvB20: serological and parasitological outcomes following intramuscular or GeneGun delivery in a mouse model of Onchocerciasis. Parasite Immunol 2000;22:249-57
   PubMed Web of Science ®Google Scholar
• Robinson HL, Montefiori DC, Johnson RP, et al. Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant poxvirus booster immunizations. Nat Med 1999;5:526-34
   PubMed Web of Science ®Google Scholar
• Feltquate DM, Heaney S, Webster RG, Robinson HL. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J Immunol 1997;158:2278-84
   PubMed Web of Science ®Google Scholar
• Wang R, Epstein J, Baraceros FM, et al. Induction of CD4+ T cell-dependent CD8+ type 1 responses in humans by a malaria DNA vaccine. PNAS 2001;98:10817-22
   PubMed Web of Science ®Google Scholar
• Marshall L, Hoyer RJ, Toomey MA, et al. Phase I study in advanced cancer patients of a diversified prime-and-boost vaccination protocol using recombinant vaccinia virus and recombinant nonreplicating avipox virus to elicit anti-carcinoembryonic antigen immune responses. J Clin Oncol 2000;18:3964-73
   PubMed Web of Science ®Google Scholar
• Rogers WO, Baird JK, Kumar A, et al. Multistage multiantigen heterologous prime boost vaccine for Plasmodium knowlesi malaria provides partial protection in Rhesus Macaques. Infect Immun 2001;69:5565-72
   PubMed Web of Science ®Google Scholar
• Amara RR, Villinger F, Altman JD, et al. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science 2001;292:69-74
   PubMed Web of Science ®Google Scholar
• Higgins LM, Lambkin I, Donnelly G, et al. In vivo phage display to identify M cell-targeting ligands. Pharm Res 2004;21:695-705
   PubMed Web of Science ®Google Scholar
• Orme I. Tuberculosis vaccines: current progress. Drugs 2005;65:2437-44
   PubMed Web of Science ®Google Scholar
• Lelouard H, Reggio H, Roy C, et al. Glycocalyx on rabbit intestinal M cells displays carbohydrate epitopes from Muc2. Infect Immun 2001;69:1061-71
   PubMed Web of Science ®Google Scholar
• Sansonetti P. Host–pathogen interactions: the seduction of molecular cross talk. Gut 2002;50(Suppl 3):iii2-8
   PubMedGoogle Scholar
• Nochi T, Yuki Y, Matsumura A, et al. A novel M cell – specific carbohydrate targeted mucosal vaccine effectively induces antigen-specific immune responses. J Exp Med 2007;204:2789-96
   PubMed Web of Science ®Google Scholar
• Issa MM, Köping-Höggård M, Tømmeraas K, et al. Targeted gene delivery with trisaccharide-substituted chitosan oligomers in vitro and after lung administration in vivo. J Control Release 2006;115:103-12
   PubMed Web of Science ®Google Scholar
• Bacon A, Makin J, Sizer PJ, et al. Carbohydrate biopolymers enhance antibody responses to mucosally delivered vaccine antigens. Infect Immun 2000;68:5764-70
   PubMed Web of Science ®Google Scholar
• Gullberg E, Keita AV, Salim SY, et al. Identification of cell adhesion molecules in the human follicle-associated epithelium that improve nanoparticle uptake into the Peyer's patches. J Pharmacol Exp Ther 2006;319:632-9
   PubMed Web of Science ®Google Scholar
• Wu Y, Wang X, Csencsits KL. M cell-targeted DNA vaccination. PNAS 2001;98:9318-23
   PubMed Web of Science ®Google Scholar
• Cox E, Verdonck F, Vanrompay D, Goddeeris B. Adjuvants modulating mucosal immune responses or directing systemic responses towards the mucosa. Vet Res 2006;37:511-39
   PubMed Web of Science ®Google Scholar
• Horwitz MA, Harth G, Dillon BJ, MasleŠa-Galić S. Enhancing the protective efficacy of Mycobacterium bovis BCG vaccination against tuberculosis by boosting with the Mycobacterium tuberculosis major secretory protein. Infect Immun 2005;73:4676-83
   PubMed Web of Science ®Google Scholar
• Kaminski RW, Turbyfill KR, Oaks EV. Mucosal adjuvant properties of the Shigella invasin complex. Infect Immun 2006;74:2856-66
   PubMed Web of Science ®Google Scholar
• Akhiani AA, Stensson A, Schön K, Lycke N. The nontoxic CTA1-DD adjuvant enhances protective immunity against Helicobacter pylori infection following mucosal immunization. J Immunol 2006;63:97-105
   Web of Science ®Google Scholar
• Johnson AG. Molecular adjuvants and immunomodulators: New approaches to immunization. Clin Microbiol Rev 1994;7:277-89
   PubMed Web of Science ®Google Scholar
• Alignani D, Maletto B, Liscovsky M, et al. Orally administered OVA/CpG-ODN induces specific mucosal and systemic immune response in young and aged mice. J Leukoc Biol 2005;77:898-905
   PubMed Web of Science ®Google Scholar
• Giri PK, Khuller GK. Is intranasal vaccination a feasible solution for tuberculosis? Expert Rev Vaccines 2008;7:1341-56
   PubMed Web of Science ®Google Scholar
• Selinsky C, Luke C, Wlock M, et al. A DNA-based vaccine for the prevention of human cytomegalovirus-associated diseases. Hum Vaccines 2005;1:16-23
   PubMed Web of Science ®Google Scholar
• Little SF, Ivins BE, Webster WM, et al. Effect of aluminum hydroxide adjuvant and formaldehyde in the formulation of rPA anthrax vaccine. Vaccine 2007;25:2771-7
   PubMed Web of Science ®Google Scholar
• Sun RWY, Chen R, Chung NPY, et al. Silver nanoparticles fabricated in Hepes buffer exhibit cytoprotective activities toward HIV-1 infected cells. Chem Commun (Camb) 2005;28(40):5059-61
   Web of Science ®Google Scholar
• Elechiguerra JL, Burt JL, Morones JR, et al. Interaction of silver nanoparticles with HIV-1. J Nanobiotechnol 2005;3:6. Published online 29 June 2005 doi:10.1186/1477-3155-3-6
   PubMedGoogle Scholar
• Maecker HT, Umetsu DT, DeKruyff RH, Levy S. DNA vaccination with cytokine fusion constructs biases the immune response to ovalbumin. Vaccine 1997;15:1687-96
   PubMed Web of Science ®Google Scholar
• Rich RR, Fleischer TA, Shearer WT, Kotzin BL, Schroeder HW Jr, editors, Clin Immunol London: Mosby, 2001
   Google Scholar